| Mrs Shannon Adkins, | |
|
621 Mount Vernon Rd, Newark, OH 43055-4615 | |
| (740) 670-7092 | |
| Not Available |
| Full Name | Mrs Shannon Adkins |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 621 Mount Vernon Rd, Newark, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316361983 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-6412 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Shannon Adkins, 7034 Upper Cambridge Way, Westerville, OH 43082-7030 Ph: () - | Mrs Shannon Adkins, 621 Mount Vernon Rd, Newark, OH 43055-4615 Ph: (740) 670-7092 |
News Archive
Biopartners GmbH has announced that it has received EU marketing authorization from the European Commission for Ribavirin Biopartners 200mg film-coated tablets. The product is intended for the treatment of chronic hepatitis C infection as part of a combination regimen with peginterferon alfa-2b or interferon alfa-2b.
With the RTS,S malaria vaccine trial results showing "moderate" success, helping to reignite "optimism about eradicating malaria entirely," "there are other big hurdles still to surmount," a New York Times editorial states.
It has long been known that disrupted sleep can increase the risk of dementia and anecdotal evidence suggests COVID-19 anxiety is having a detrimental effect on sleep.
"Participation in a physically active lifestyle appears to be critical to preserving high physical function in relatively fit, healthy, middle-aged men and women," according to Dr. Melvyn Hillsdon of University College London and colleagues.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
› Verified 2 days ago
Katheryn Perse, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 145 N Quentin Rd, Newark, OH 43055 Phone: 740-349-6084 | |
Colleen Kovacs, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 W Church St, Newark, OH 43055 Phone: 740-345-3400 | |
Miss Kelsey Lynne Ryan, MS,-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 119 Union St, Newark, OH 43055 Phone: 614-271-9325 Fax: 614-271-9325 | |
Executive Rehab Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1945 Tamarack Rd, Newark, OH 43055 Phone: 740-349-9777 | |
Mrs. Jane Ann Snow, MA. ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1555 Woodridge Dr, Newark, OH 43055 Phone: 740-344-9199 | |
Leslie Marcelain, SLP M. ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1945 Tamarack Rd, Newark, OH 43055 Phone: 740-349-9777 | |
Mrs. Robyn Cormican, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 621 Mount Vernon Rd, Newark, OH 43055 Phone: 740-670-7095 Fax: 740-670-7039 |